1
|
Barbosa MDM, de Lima LMA, Alves WADS, de Lima EKB, da Silva LA, da Silva TD, Postal K, Ramadan M, Kostenkova K, Gomes DA, Nunes GG, Pereira MC, da Silva WE, Belian MF, Crans DC, Lira EC. In Vitro, Oral Acute, and Repeated 28-Day Oral Dose Toxicity of a Mixed-Valence Polyoxovanadate Cluster. Pharmaceuticals (Basel) 2023; 16:1232. [PMID: 37765040 PMCID: PMC10536805 DOI: 10.3390/ph16091232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 07/21/2023] [Accepted: 08/13/2023] [Indexed: 09/29/2023] Open
Abstract
Polyoxovanadates (POV) are a subgroup of polyoxometalates (POM), which are nanosized clusters with reported biological activities. This manuscript describes the first toxicity evaluation of a mixed-valence polyoxovanadate, pentadecavanadate, (Me4N)6[V15O36Cl], abbreviated as V15. Cytotoxicity experiments using peripheral blood mononuclear cells (PBMC), larvae of Artemia salina Leach, and in vivo oral acute and repeated 28-day doses in mice was carried out. The LC50 values in PBMC cells and A. salina were 17.5 ± 5.8 μmol L-1, and 17.9 µg L-1, respectively, which indicates high cytotoxic activity. The toxicity in mice was not observed upon acute exposure in a single dose, however, the V15 repeated 28-day oral administration demonstrated high toxicity using 25 mg/kg, 50 mg/kg and, 300 mg/kg doses. The biochemical and hematological analyses during the 28-day administration of V15 showed significant alteration of the metabolic parameters related to the kidney and liver, suggesting moderate toxicity. The V15 toxicity was attributed to the oxidative stress and lipid peroxidation, once thiobarbituric acid (TBAR) levels significantly increased in both males and females treated with high doses of the POV and also in males treated with a lower dose of the POV. This is the first study reporting a treatment-related mortality in animals acutely administrated with a mixed-valence POV, contrasting with the well-known, less toxic decavanadate. These results document the toxicity of this mixed-valence POV, which may not be suitable for biomedical applications.
Collapse
Affiliation(s)
- Mariana de M. Barbosa
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Lidiane M. A. de Lima
- Departamento de Química, Universidade Federal Rural de Pernambuco, Recife 52171-900, PE, Brazil; (L.M.A.d.L.); (W.E.d.S.); (M.F.B.)
| | - Widarlane A. da S. Alves
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Eucilene K. B. de Lima
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Luzia A. da Silva
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Thiago D. da Silva
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Kahoana Postal
- Centro Politécnico, Departamento de Química, Universidade Federal do Paraná, Curitiba 81530-900, PR, Brazil; (K.P.); (G.G.N.)
| | - Mohammad Ramadan
- Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA; (M.R.); (K.K.)
| | - Kateryna Kostenkova
- Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA; (M.R.); (K.K.)
| | - Dayane A. Gomes
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Giovana G. Nunes
- Centro Politécnico, Departamento de Química, Universidade Federal do Paraná, Curitiba 81530-900, PR, Brazil; (K.P.); (G.G.N.)
| | - Michelly C. Pereira
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| | - Wagner E. da Silva
- Departamento de Química, Universidade Federal Rural de Pernambuco, Recife 52171-900, PE, Brazil; (L.M.A.d.L.); (W.E.d.S.); (M.F.B.)
| | - Mônica F. Belian
- Departamento de Química, Universidade Federal Rural de Pernambuco, Recife 52171-900, PE, Brazil; (L.M.A.d.L.); (W.E.d.S.); (M.F.B.)
| | - Debbie C. Crans
- Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA; (M.R.); (K.K.)
- Cell and Molecular Biology Program, Colorado State University, Fort Collins, CO 80523, USA
| | - Eduardo C. Lira
- Centro de Biociências, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, Recife 50670-901, PE, Brazil; (M.d.M.B.); (W.A.d.S.A.); (E.K.B.d.L.); (L.A.d.S.); (T.D.d.S.); (D.A.G.); (M.C.P.)
| |
Collapse
|
2
|
Rivas-García L, López-Varela A, Quiles JL, Montes-Bayón M, Aranda P, Llopis J, Sánchez-González C. Elucidating the Therapeutic Potential of Bis(Maltolato)OxoVanadium(IV): The Protective Role of Copper in Cellular Metabolism. Int J Mol Sci 2023; 24:ijms24119367. [PMID: 37298322 DOI: 10.3390/ijms24119367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 05/23/2023] [Accepted: 05/25/2023] [Indexed: 06/12/2023] Open
Abstract
Vanadium (V) is a trace mineral whose biological activity, role as a micronutrient, and pharmacotherapeutic applications remain unknown. Over the last years, interest in V has increased due to its potential use as an antidiabetic agent mediated by its ability to improve glycemic metabolism. However, some toxicological aspects limit its potential therapeutic application. The present study aims to evaluate the effect of the co-treatment with copper (Cu) and bis(maltolato)oxovanadium(IV) (BMOV) as a possible strategy to reduce the toxicity of BMOV. Treating hepatic cells with BMOV reduced cell viability under the present conditions, but cell viability was corrected when cells were co-incubated with BMOV and Cu. Additionally, the effect of these two minerals on nuclear and mitochondrial DNA was evaluated. Co-treatment with both metals reduced the nuclear damage caused by BMOV. Moreover, treatment with these two metals simultaneously tended to reduce the ND1/ND4 deletion of the mitochondrial DNA produced with the treatment using BMOV alone. In conclusion, these results showed that combining Cu and V could effectively reduce the toxicity associated with V and enhance its potential therapeutic applications.
Collapse
Affiliation(s)
- Lorenzo Rivas-García
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Centre, University of Granada, 18016 Armilla, Spain
- Sport and Health Research Centre, University of Granada, C/Menéndez Pelayo 32, 18016 Granada, Spain
| | - Alfonso López-Varela
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Centre, University of Granada, 18016 Armilla, Spain
| | - José L Quiles
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Centre, University of Granada, 18016 Armilla, Spain
- Research and Development Functional Food Centre (CIDAF), Health Science Technological Park, Avenida del Conocimiento 37, 18016 Granada, Spain
- Research Group on Foods, Nutritional Biochemistry and Health, Universidad Europea del Atlántico, Isabel Torres 21, 39011 Santander, Spain
| | - María Montes-Bayón
- Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Department of Physical and Analytical Chemistry, Faculty of Chemistry, University of Oviedo, C/ Julián Clavería 8, 33006 Oviedo, Spain
| | - Pilar Aranda
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Centre, University of Granada, 18016 Armilla, Spain
- Sport and Health Research Centre, University of Granada, C/Menéndez Pelayo 32, 18016 Granada, Spain
| | - Juan Llopis
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Centre, University of Granada, 18016 Armilla, Spain
- Sport and Health Research Centre, University of Granada, C/Menéndez Pelayo 32, 18016 Granada, Spain
| | - Cristina Sánchez-González
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Centre, University of Granada, 18016 Armilla, Spain
- Sport and Health Research Centre, University of Granada, C/Menéndez Pelayo 32, 18016 Granada, Spain
| |
Collapse
|
3
|
Effect of Bis(maltolato)oxovanadium(IV) on Zinc, Copper, and Manganese Homeostasis and DMT1 mRNA Expression in Streptozotocin-Induced Hyperglycemic Rats. BIOLOGY 2022; 11:biology11060814. [PMID: 35741335 PMCID: PMC9219771 DOI: 10.3390/biology11060814] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 05/20/2022] [Accepted: 05/23/2022] [Indexed: 02/07/2023]
Abstract
Our aim was to examine whether vanadium (IV) corrects alterations in zinc, copper and manganese homeostasis, observed in streptozotocin-induced hyperglycemic rats, and whether such changes are related to divalent metal transporter 1 (DMT1) mRNA expression, and antioxidant and proinflammatory parameters. Four groups of Wistar rats were examined: control; hyperglycemic (H); hyperglycemic treated with 1 mg V/day (HV); and hyperglycemic treated with 3 mg V/day (HVH). Vanadium was supplied in drinking water as bis(maltolato)oxovanadium(IV) for five weeks. Zinc, copper and manganese were measured in food, excreta, serum and tissues. DMT1 mRNA expression was quantified in the liver. Hyperglycemic rats showed increased Zn and Cu absorption and content in the liver, serum, kidneys and femurs; DMT1 expression also increased (p < 0.05 in all cases). HV rats showed no changes compared to H rats other than decreased DMT1 expression (p < 0.05). In the HVH group, decreased absorption and tissular content of studied elements (p < 0.05 in all cases) and DMT1 expression compared to H (p < 0.05) were observed. Liver zinc, copper and manganese content correlated positively with glutathione peroxidase activity and negatively with catalase activity (p < 0.05 in both cases). In conclusion, treatment with 3 mg V/d reverted the alterations in zinc and copper homeostasis caused by hyperglycemia, possibly facilitated by decreased DMT1 expression.
Collapse
|
4
|
Sánchez-González C, Rivas-García L, Rodríguez-Nogales A, Algieri F, Gálvez J, Aranda P, Montes-Bayón M, Llopis J. Vanadium Decreases Hepcidin mRNA Gene Expression in STZ-Induced Diabetic Rats, Improving the Anemic State. Nutrients 2021; 13:nu13041256. [PMID: 33920401 PMCID: PMC8069891 DOI: 10.3390/nu13041256] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Revised: 04/05/2021] [Accepted: 04/08/2021] [Indexed: 12/26/2022] Open
Abstract
Diabetes is a disease with an inflammatory component that courses with an anemic state. Vanadium (V) is an antidiabetic agent that acts by stimulating insulin signaling. Hepcidin blocks the intestinal absorption of iron and the release of iron from its deposits. We aim to investigate the effect of V on hepcidin mRNA expression and its consequences on the hematological parameters in streptozotocin-induced diabetic Wistar rats. Control healthy rats, diabetic rats, and diabetic rats treated with 1 mgV/day were examined for five weeks. The mineral levels were measured in diet and serum samples. Hepcidin expression was quantified in liver samples. Inflammatory and hematological parameters were determined in serum or whole blood samples. The inflammatory status was higher in diabetic than in control rats, whereas the hematological parameters were lower in the diabetic rats than in the control rats. Hepcidin mRNA expression was significantly lower in the V-treated diabetic rats than in control and untreated diabetic rats. The inflammatory status remained at a similar level as the untreated diabetic group. However, the hematological profile improved after the V-treatment, reaching similar levels to those found in the control group. Serum iron level was higher in V-treated than in untreated diabetic rats. We conclude that V reduces gene expression of hepcidin in diabetic rats, improving the anemic state caused by diabetes.
Collapse
Affiliation(s)
- Cristina Sánchez-González
- Biomedical Research Centre (CIBM), Sport and Health Research Centre (IMUDs), Institute of Nutrition and Food Technology, Department of Physiology, University of Granada, E-18071 Granada, Spain; (L.R.-G.); (P.A.); (J.L.)
- Correspondence: ; Tel.: +34-958241000 (ext. 20320)
| | - Lorenzo Rivas-García
- Biomedical Research Centre (CIBM), Sport and Health Research Centre (IMUDs), Institute of Nutrition and Food Technology, Department of Physiology, University of Granada, E-18071 Granada, Spain; (L.R.-G.); (P.A.); (J.L.)
| | - Alba Rodríguez-Nogales
- CIBERehd, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Department of Pharmacology, CIBM, University of Granada, E-18071 Granada, Spain; (A.R.-N.); (F.A.); (J.G.)
| | - Francesca Algieri
- CIBERehd, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Department of Pharmacology, CIBM, University of Granada, E-18071 Granada, Spain; (A.R.-N.); (F.A.); (J.G.)
| | - Julio Gálvez
- CIBERehd, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Department of Pharmacology, CIBM, University of Granada, E-18071 Granada, Spain; (A.R.-N.); (F.A.); (J.G.)
| | - Pilar Aranda
- Biomedical Research Centre (CIBM), Sport and Health Research Centre (IMUDs), Institute of Nutrition and Food Technology, Department of Physiology, University of Granada, E-18071 Granada, Spain; (L.R.-G.); (P.A.); (J.L.)
| | - María Montes-Bayón
- Department of Physical and Analytical Chemistry, Faculty of Chemistry, University of Oviedo, 33007 Oviedo, Spain;
| | - Juan Llopis
- Biomedical Research Centre (CIBM), Sport and Health Research Centre (IMUDs), Institute of Nutrition and Food Technology, Department of Physiology, University of Granada, E-18071 Granada, Spain; (L.R.-G.); (P.A.); (J.L.)
| |
Collapse
|
5
|
Quiles JL, Sánchez-González C, Vera-Ramírez L, Giampieri F, Navarro-Hortal MD, Xiao J, Llopis J, Battino M, Varela-López A. Reductive Stress, Bioactive Compounds, Redox-Active Metals, and Dormant Tumor Cell Biology to Develop Redox-Based Tools for the Treatment of Cancer. Antioxid Redox Signal 2020; 33:860-881. [PMID: 32064905 DOI: 10.1089/ars.2020.8051] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Significance: Cancer is related to redox biology from many points of view, such as initiation and promotion, metabolism and growth, invasion and metastasis, vascularization, or through the interaction with the immune system. In addition, this extremely complex relationship depends on the redox homeostasis of each cellular compartment, which might be used to fight cancer. Recent Advances: New ways of modulating specific and little explored aspects of redox biology have been revealed, as well as new delivery methods or uses of previously known treatments against cancer. Here, we review the latest experimental evidence regarding redox biology in cancer treatment and analyze its potential impact in the development of improved and more effective antineoplastic therapies. Critical Issues: A critical issue that deserves particular attention is the understanding that both extremes of redox biology (i.e., oxidative stress [OS] and reductive stress) might be useful or harmful in relation to cancer prevention and treatment. Future Directions: Additional research is needed to understand how to selectively induce reductive or OS adequately to avoid cancer proliferation or to induce cancer cell death.
Collapse
Affiliation(s)
- José L Quiles
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Center, University of Granada, Granada, Spain.,College of Food Science and Technology, Northwest University, Xi'an, China
| | - Cristina Sánchez-González
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Center, University of Granada, Granada, Spain
| | - Laura Vera-Ramírez
- Department of Genomic Medicine, GENYO: Centre for Genomics and Oncology (Pfizer-University of Granada and Andalusian Regional Government), Granada, Spain
| | - Francesca Giampieri
- College of Food Science and Technology, Northwest University, Xi'an, China.,Department of Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy
| | - M Dolores Navarro-Hortal
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Center, University of Granada, Granada, Spain
| | - Jianbo Xiao
- International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang, China
| | - Juan Llopis
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Center, University of Granada, Granada, Spain
| | - Maurizio Battino
- Department of Clinical Sciences, Università Politecnica delle Marche, Ancona, Italy.,International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang, China.,Nutrition and Food Science Group, Department of Analytical and Food Chemistry, CITACA, CACTI, University of Vigo, Vigo, Spain
| | - Alfonso Varela-López
- Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Center, University of Granada, Granada, Spain
| |
Collapse
|
6
|
Ścibior A, Pietrzyk Ł, Plewa Z, Skiba A. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends. J Trace Elem Med Biol 2020; 61:126508. [PMID: 32305626 PMCID: PMC7152879 DOI: 10.1016/j.jtemb.2020.126508] [Citation(s) in RCA: 109] [Impact Index Per Article: 27.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Revised: 02/25/2020] [Accepted: 03/19/2020] [Indexed: 01/21/2023]
Abstract
BACKGROUND Vanadium (V) is an element with a wide range of effects on the mammalian organism. The ability of this metal to form organometallic compounds has contributed to the increase in the number of studies on the multidirectional biological activity of its various organic complexes in view of their application in medicine. OBJECTIVE This review aims at summarizing the current state of knowledge of the pharmacological potential of V and the mechanisms underlying its anti-viral, anti-bacterial, anti-parasitic, anti-fungal, anti-cancer, anti-diabetic, anti-hypercholesterolemic, cardioprotective, and neuroprotective activity as well as the mechanisms of appetite regulation related to the possibility of using this element in the treatment of obesity. The toxicological potential of V and the mechanisms of its toxic action, which have not been sufficiently recognized yet, as well as key information about the essentiality of this metal, its physiological role, and metabolism with certain aspects on the timeline is collected as well. The report also aims to review the use of V in the implantology and industrial sectors emphasizing the human health hazard as well as collect data on the directions of further research on V and its interactions with Mg along with their character. RESULTS AND CONCLUSIONS Multidirectional studies on V have shown that further analyses are still required for this element to be used as a metallodrug in the fight against certain life-threatening diseases. Studies on interactions of V with Mg, which showed that both elements are able to modulate the response in an interactive manner are needed as well, as the results of such investigations may help not only in recognizing new markers of V toxicity and clarify the underlying interactive mechanism between them, thus improving the medical application of the metals against modern-age diseases, but also they may help in development of principles of effective protection of humans against environmental/occupational V exposure.
Collapse
Key Words
- 3-HMG-CoA, 3-hydroxy-3-methyl-glutaryl-CoA
- AIDS, acquired immune deficiency syndrome
- ALB, albumin
- ALP, alkaline phosphatase
- AS, antioxidant status
- Akt, protein kinase B (PKB)
- AmD, Assoc American Dietetic Association
- Anti-B, anti-bacterial
- Anti-C, anti-cancer
- Anti-D, anti-diabetic
- Anti-F, anti-fungal
- Anti-O, anti-obesity
- Anti-P, anti-parasitic
- Anti-V, anti-viral
- Anti−HC, anti-hypercholesterolemic
- ApoA-I, apolipoprotein A
- ApoB, apolipoprotein B
- B, bone
- BCOV, bis(curcumino)oxavanadyl
- BEOV, bis(ethylmaltolato)oxovanadium
- BMOV, bis(maltolato)oxavanadium(IV)
- Bim, Blc-2 interacting mediator of cell death
- Biological role
- BrOP, bromoperoxidase
- C, cholesterol
- C/EBPα, CCAAT-enhancer-binding protein α
- CD4, CD4 receptor
- CH, cerebral hemisphere
- CHO-K1, Chinese hamster ovary cells
- CXCR-4, CXCR-4 chemokine co-receptor
- Cardio-P, cardioprotective
- Citrate-T, citrate transporter
- CoA, coenzyme A
- Cyt c, cytochrome c
- DM, diabetes mellitus
- ELI, extra low interstitial
- ERK, extracellular regulated kinase
- FHR, fructose hypertensive rats
- FKHR/FKHR1/AFX, class O members of the forkhead transcription factor family
- FLIP, FLICE-inhibitory protein
- FOXOs, forkhead box class O family member proteins
- FPP, farnesyl-pyrophosphate
- FasL, Fas ligand, FER: ferritin
- GI, gastrointestinal
- GLU, glucose
- GLUT-4, glucose transporter type 4
- GPP, geranyl-pyrophosphate
- GPT, glutamate-pyruvate transaminase
- GR, glutathione reductase
- GSH, reduced glutathione
- GSSG, disulfide glutathione
- HDL, high-density lipoproteins
- HDL-C, HDL cholesterol
- HIV, human immunodeficiency virus
- HMMF, high molecular mass fraction
- HOMA-IR, insulin resistance index
- Hb, hemoglobin
- HbF, hemoglobin fraction
- Hyper-LEP, hyperleptynemia
- IDDM, insulin-dependent diabetes mellitus
- IGF-IR, insulin-like growth factor receptor
- IL, interleukin
- INS, insulin
- INS-R, insulin resistance
- INS-S, insulin sensitivity
- IPP, isopentenyl-5-pyrophosphate
- IRS, insulin receptor tyrosine kinase substrate
- IgG, immunoglobulin G
- Industrial importance
- Interactions
- JAK2, Janus kinase 2
- K, kidney
- L, liver
- L-AA, L-ascorbic acid
- LDL, low-density lipoproteins
- LDL-C, LDL cholesterol
- LEP, leptin
- LEP-R, leptin resistance
- LEP-S, leptin sensitivity
- LEPS, the concentration of leptin in the serum
- LMMF, low molecular mass fraction
- LPL, lipoprotein lipase
- LPO, lipid peroxidation
- Lactate-T, lactate transporter
- M, mitochondrion
- MEK, ERK kinase activator
- MRC, mitochondrial respiratory chain
- NAC, N-acetylcysteine
- NEP, neutral endopeptidase
- NIDDM, noninsulin-dependent diabetes mellitus
- NO, nitric oxide
- NPY, neuropeptide Y
- NaVO3, sodium metavanadate
- Neuro-P, neuroprotective
- OXPHOS, oxidative phosphorylation
- Organic-AT, organic anion transporter
- Over-W, over-weight
- P, plasma
- PANC-1, pancreatic ductal adenocarcinoma cells
- PARP, poly (ADP-ribose) polymerase
- PLGA, (Poly)Lactide-co-Glycolide copolymer
- PO43−, phosphate ion
- PPARγ, peroxisome-activated receptor γ
- PTK, tyrosine protein kinase
- PTP, protein tyrosine phosphatase
- PTP-1B, protein tyrosine phosphatase 1B
- Pharmacological activity
- Pi3K, phosphoinositide 3-kinase (phosphatidylinositol 3-kinase)
- RBC, erythrocytes
- ROS, reactive oxygen species
- RT, reverse transcriptase
- SARS, severe acute respiratory syndrome
- SAcP, acid phosphatase secreted by Leshmania
- SC-Ti-6Al-4V, surface-coated Ti-6Al-4V
- SHR, spontaneously hypertensive rats
- SOD, superoxide dismutase
- STAT3, signal transducer/activator of transcription 3
- Sa, mean roughness
- Sq, root mean square roughness
- Sz, ten-point height
- TC, total cholesterol
- TG, triglycerides
- TS, transferrin saturation
- Tf, transferrin
- TfF, transferrin fraction
- TiO2, nHA:Ag-Ti-6Al-4V: titanium oxide-based coating containing hydroxyapatite nanoparticle and silver particles
- Top-IB, IB type topoisomerase
- Toxicological potential
- V, vanadium
- V-BrPO, vanadium bromoperoxidase
- V-DLC, diamond-like layer with vanadium
- V5+/V4+, pentavalent/tetravalent vanadium
- VO2+, vanadyl cation
- VO2+-FER, vanadyl-ferritin complex
- VO4-/VO3-, vanadate anion
- VO43-, vanadate ion
- VS, vanadyl sulfate
- Vanadium
- WB, whole blood
- ZDF rats, Zucker diabetic fatty rats
- ZF rats, Zucker fatty rats
- breakD, breakdown
- eNOS, endothelial nitric oxide synthase
- mo, months
- n-HA, nano-hydroxyapatite
- pRb, retinoblastoma protein
- wk, weeks
Collapse
Affiliation(s)
- Agnieszka Ścibior
- Laboratory of Oxidative Stress, Centre for Interdisciplinary Research, The John Paull II Catholic University of Lublin, Poland
| | - Łukasz Pietrzyk
- Laboratory of Oxidative Stress, Centre for Interdisciplinary Research, The John Paull II Catholic University of Lublin, Poland
- Department of Didactics and Medical Simulation, Chair of Anatomy, Medical University of Lublin, Poland
| | - Zbigniew Plewa
- Department of General, Oncological, and Minimally Invasive Surgery, 1 Military Clinical Hospital with the Outpatient Clinic in Lublin, Poland
| | - Andrzej Skiba
- Military Clinical Hospital with the Outpatient Clinic in Lublin, Poland
| |
Collapse
|
7
|
Ścibior A, Hus I, Mańko J, Jawniak D. Evaluation of the level of selected iron-related proteins/receptors in the liver of rats during separate/combined vanadium and magnesium administration. J Trace Elem Med Biol 2020; 61:126550. [PMID: 32464446 DOI: 10.1016/j.jtemb.2020.126550] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Revised: 04/17/2020] [Accepted: 05/08/2020] [Indexed: 12/23/2022]
Abstract
BACKGROUND The current knowledge about the effects of vanadium (V) on iron (Fe)-related proteins and Fe homeostasis (which is regulated at the systemic, organelle, and cellular levels) is still insufficient. OBJECTIVE This fact and our earlier results prompted us to conduct studies with the aim to explain the mechanism of anemia accompanied by a rise in hepatic and splenic Fe deposition in rats receiving sodium metavanadate (SMV) separately and in combination with magnesium sulfate (MS). RESULTS We demonstrated for the first time that SMV (0.125 mg V/mL) administered to rats individually and in conjunction with MS (0.06 mg Mg/mL) for 12 weeks did not cause significant differences in the hepatic hepcidin (Hepc) and hemojuvelin (HJV) concentrations, compared to the control. In comparison with the control, there were no significant changes in the concentration of transferrin receptor 1 (TfR1) in the liver of rats treated with SMV and MS alone (in both cases only a downward trend of 14% and 15% was observed). However, a significant reduction in the hepatic TfR1 level was found in rats receiving SMV and MS simultaneously. In turn, the concentration of transferrin receptor 2 (TfR2) showed an increasing trend in the liver of rats treated with SMV and/or MS. CONCLUSIONS The experimental data suggest that the pathomechanism of the SMV-induced anemia is not associated with the effect of V on the concentration of Hepc in the liver, as confirmed by the unaltered hepatic HJV and TfR1 levels. Therefore, further studies are needed in order to check whether anemia that developed in the rats at the SMV administration (a) results from the inhibitory effect of V on erythropoietin (EPO) production, (b) is related to the effect of V on the induction of matriptase-2 (TMPRSS6) expression, or (c) is associated with the influence of this metal on haem synthesis.
Collapse
Affiliation(s)
- Agnieszka Ścibior
- Laboratory of Oxidative Stress, Centre for Interdisciplinary Research, The John Paul II Catholic University of Lublin, Poland.
| | - Iwona Hus
- Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
| | - Joanna Mańko
- Clinic of Haematooncology and Bone Marrow Transplantation, Medical University, Lublin, Poland.
| | - Dariusz Jawniak
- Clinic of Haematooncology and Bone Marrow Transplantation, Medical University, Lublin, Poland.
| |
Collapse
|
8
|
In vitro study of the protective effect of manganese against vanadium-mediated nuclear and mitochondrial DNA damage. Food Chem Toxicol 2019; 135:110900. [PMID: 31654710 DOI: 10.1016/j.fct.2019.110900] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Revised: 09/24/2019] [Accepted: 10/18/2019] [Indexed: 12/29/2022]
Abstract
We aimed to study the effect of vanadium(V) exposure on cell viability, nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) and to elucidate if these effects can be reverted by co-exposure to V and manganese (Mn). HepG2 cells were incubated with various concentrations of bis(maltolato)oxovanadium(IV) or MnCl2 for 32 h for viability study. The higher concentrations (59 μM V, 54 nM Mn and 59 μM V+54 nM Mn) were used to study DNA damage and uptake of V and Mn. Comet assay was used for the study of nDNA damage; mtDNA damage was studied by determining deletions and number of copies of the ND1/ND4 mtDNA region. Cellular content of V and Mn was determined using ICPMS. Cellular exposure to 59 μM V decreased viability (14%) and damaged nDNA and mtDNA. This effect was partially prevented by the co-exposure to V + Mn. Exposure to V increased the cellular content of V and Mn (812.3% and 153.5%, respectively). Exposure to Mn decreased the content of V and Mn (62% and 56%, respectively). Exposure to V + Mn increased V (261%) and decreased Mn (56%) content. The positive effects on cell viability and DNA damage when incubated with V + Mn could be due to the Mn-mediated inhibition of V uptake.
Collapse
|
9
|
Ortiz-López CS, Veses V, Garcia-Bautista JA, Jovani-Sancho MDM. Risk factors for the presence of dental black plaque. Sci Rep 2018; 8:16752. [PMID: 30425313 PMCID: PMC6233187 DOI: 10.1038/s41598-018-35240-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Accepted: 10/31/2018] [Indexed: 01/12/2023] Open
Abstract
In order to evaluate risk factors related to the presence of extrinsic dental black stain, a total of 94 orally healthy volunteers (47 individuals with dental black stain and 47 individuals without dental black stain) were recruited from ten different dental clinics in Valencia and Castellón (Spain). Data regarding their oral hygiene, dietary habits, and oral health status were gathered by questionnaire. Samples of dental plaque, saliva and drinking water were collected for chemical analysis. Three factors were found to be statistically significantly associated with dental black stain, (i) consuming water with high iron content, (ii) consuming water with high pH, and (iii) having a high salivary pH. Other factors such as smoking, taking iron supplements or consuming caffeinated drinks were not found to be risk factors for the presence of black stain. A multivariate logistic regression analysis showed that drinking tap or osmosis-purified water and lower levels of salivary iron increase the risk of having dental black stain. Overall, several risk factors for the presence of dental black stain have been identified. The main modifiable risk factor identified in this study was the consumption of tap or osmosis drinking water.
Collapse
Affiliation(s)
- Claudia S Ortiz-López
- Department of Dentistry, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Moncada, Spain
| | - Veronica Veses
- Department of Biomedical Sciences, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Moncada, Spain.
| | - Jose A Garcia-Bautista
- Director of Laboratory Services, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Moncada, Spain
| | - Maria Del Mar Jovani-Sancho
- Department of Dentistry, Faculty of Health Sciences, Universidad CEU Cardenal Herrera, CEU Universities, Moncada, Spain
| |
Collapse
|
10
|
Evaluation of lipid peroxidation and the level of some elements in rat erythrocytes during separate and combined vanadium and magnesium administration. Chem Biol Interact 2018; 293:1-10. [PMID: 30028963 DOI: 10.1016/j.cbi.2018.07.014] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Revised: 07/02/2018] [Accepted: 07/16/2018] [Indexed: 12/18/2022]
Abstract
The impact of vanadium (V) and magnesium (Mg) as sodium metavanadate (SMV, 0.125 mg V/ml) and magnesium sulfate (MS, 0.06 mg Mg/ml) on lipid peroxidation (LPO) and selected elements in the rat erythrocytes (RBCs) was investigated. Relationships between some indices determined in RBC were also studied. SMV alone (Group II) elevated the malondialdehyde level (MDARBC) (by 95% and 60%), compared with the control (Group I) and MS-supplemented rats (Group III), respectively, reduced the concentration of CuRBC (by 23.5%), in comparison with Group I, but did not change the levels of NaRBC, KRBC, and CaRBC, whereas MS alone (Group III) only reduced the CuRBC concentration (by 22%), compared with Group I. The SMV + MS combination (Group IV) reduced and elevated the CuRBC (by 24%) and CaRBC (by 111%) concentrations, respectively, in comparison with Groups I and III, and these changes were induced by the V-Mg antagonistic and synergistic interaction, respectively. The combined SMV + MS effect also enhanced the MDARBC level, compared with Groups I (by 79%) and III (by 47%) and slightly limited its concentration, compared with Group II, which, in turn, resulted from the distinct trend toward the V-Mg antagonistic interaction. We can conclude that V (as SMV) is able to stimulate LPO in rat RBCs and that V-Mg interactive effects are involved in changes in CuRBC, CaRBC, and MDARBC. Further studies are needed to elucidate the exact mechanisms of the V-Mg antagonistic/synergistic interactions and to provide insight into the biochemical mechanisms of changes in rats suffering from anemia [1], characterized by a disrupted antioxidant barrier in RBCs [2] and an intensified free radical process in these cells.
Collapse
|
11
|
Sanchez-Gonzalez C, Moreno L, Lopez-Chaves C, Nebot E, Pietschmann P, Rodriguez-Nogales A, Galvez J, Montes-Bayon M, Sanz-Medel A, Llopis J. Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic rats. Metallomics 2017; 9:258-267. [PMID: 28194470 DOI: 10.1039/c6mt00272b] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The aim of this study was to examine whether alterations caused by diabetes in calcium homeostasis, expression of osteopontin and the microarchitecture of bone are corrected by exposure to vanadium. Four study groups were examined over a period of five weeks: control (C), diabetic (DM), diabetic treated with 1 mg V per d (DMV), and diabetic treated with 3 mg V per d (DMVH). Vanadium was supplied in drinking water as bis(maltolato)oxovanadium(iv). Calcium was measured in the food, faeces, urine, serum, kidneys, liver, muscles, and femur. Osteopontin gene expression was determined in the liver, and the bone microarchitecture was studied with the aid of micro-computed tomography. In the DM group, food intake as well as calcium absorbed and retained and liver osteopontin mRNA increased, while Ca in the serum and femur decreased, and the bone microarchitecture worsened, in comparison with the control. In the DMV group, the amount of Ca absorbed and retained was similar to DM rats. Although the Ca content in the femur increased and osteopontin mRNA decreased, there were no significant changes in the bone microarchitecture, in comparison to the DM rats. In the DMVH group, the amount of Ca absorbed and retained, and the serum and femur content were equivalent to the control. The levels of osteopontin mRNA decreased and bone mineralization improved, compared to the DM group. We conclude that treatment with 3 mg V per d of the glucose lowering agent bis(maltolato)oxovanadium(iv) causes a decrease in osteopontin mRNA, which could favour the normalization of changes in Ca homeostasis and bone microarchitecture, both at the cortical and trabecular levels, caused by diabetes.
Collapse
Affiliation(s)
- Cristina Sanchez-Gonzalez
- CIBM, IMUDS, Department of Physiology, Faculty of Pharmacy, University of Granada, E-18071 Granada, Spain.
| | - Laura Moreno
- CIBM, IMUDS, Department of Physiology, Faculty of Pharmacy, University of Granada, E-18071 Granada, Spain.
| | - Carlos Lopez-Chaves
- CIBM, IMUDS, Department of Physiology, Faculty of Pharmacy, University of Granada, E-18071 Granada, Spain.
| | - Elena Nebot
- CIBM, IMUDS, Department of Physiology, Faculty of Pharmacy, University of Granada, E-18071 Granada, Spain. and Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria
| | - Peter Pietschmann
- Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria
| | | | - Julio Galvez
- CIBERehd, Department of Pharmacology, University of Granada, 18071 Granada, Spain
| | - María Montes-Bayon
- Department of Analytical Chemistry, Faculty of Chemistry, University of Oviedo, 33007 Oviedo, Spain.
| | - Alfredo Sanz-Medel
- Department of Analytical Chemistry, Faculty of Chemistry, University of Oviedo, 33007 Oviedo, Spain.
| | - Juan Llopis
- CIBM, IMUDS, Department of Physiology, Faculty of Pharmacy, University of Granada, E-18071 Granada, Spain.
| |
Collapse
|
12
|
Vanadium (V) and magnesium (Mg) - In vivo interactions: A review. Chem Biol Interact 2016; 258:214-33. [PMID: 27620816 DOI: 10.1016/j.cbi.2016.09.007] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Revised: 08/26/2016] [Accepted: 09/08/2016] [Indexed: 02/08/2023]
Abstract
Vanadium (V) and magnesium (Mg) arouse interest of many research centres worldwide. Many aspects of their action have already been recognized but some of them have not been fully elucidated yet. Relatively little is known about the mechanisms of absorption, transport, and excretion of V. There is also a lack of sufficient data about the most sensitive biomarkers of V toxicity and the mechanisms of its toxic action, which have not been fully explained yet. There is also a lack of comprehensive research on the consequences, character, and mechanisms of mutual interactions of V (which has strong pro-oxidant properties) with elements with an antioxidant potential such as Mg, the recognition of which, besides the cognitive value, may have great practical importance. It should be highlighted that the question of interactions between elements is always up to date and it is still an important issue in toxicology. A comprehensive research on interactions of V with Mg can be particularly important in the studies of the usage of V (which has a narrow margin of safety) in the treatment of certain diseases in humans, especially diabetes, which is accompanied by changes in the level of Mg in the tissues and weakening of the antioxidant barrier and oxidative stress. Therefore, the aspect concerning the possible interaction of V (as a potent pro-oxidant) with Mg (as an antioxidant) was the subject of our special interest. In addition, the examination of the effects of the interactions between V and Mg is very important especially for extending the knowledge of the mechanism of the influence of V on the organism and a potential role of Mg (which is characterized by a wide therapeutic window) in prevention of V toxicity. This review summarizes the most important results obtained from our experiments in a rodent model referring to the interactions of V with Mg on the background of the in vivo experimental data published by other researchers of this issue. Our studies have shown that V and Mg supplied in combination are able to modulate the response in an interactive manner to produce a specific effect that is distinct from that observed during separate administration thereof. The present report also provides the most important information about the effects of the action of V and Mg with other metals.
Collapse
|